Planta Med 2018; 84(09/10): 613-626
DOI: 10.1055/a-0605-3786
Reviews
Georg Thieme Verlag KG Stuttgart · New York

A Review of the Toxicity of Compounds Found in Herbal Dietary Supplements

Amy Hudson   *
1   Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, Alabama, USA
,
Elizabeth Lopez   *
1   Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, Alabama, USA
,
Ahmad J. Almalki
1   Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, Alabama, USA
2   Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia
,
Amy L. Roe
3   The Procter & Gamble Company, Cincinnati, Ohio, USA
,
Angela I. Calderón
1   Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, Alabama, USA
› Author Affiliations
Further Information

Publication History

received 15 November 2017
revised 31 March 2018

accepted 04 April 2018

Publication Date:
19 April 2018 (online)

   Permissions and Reprints

Abstract

Use of herbal dietary supplements by the public is common and has been happening for centuries. In the United States, the Food and Drug Administration has a limited scope of regulation over marketed herbal dietary supplements, which may contain toxic botanical compounds that pose a public health risk. While the Food and Drug Administration has made efforts to prohibit the sale of unsafe herbal dietary supplements, numerous reports have proliferated of adverse events due to these supplements. This literature review investigates bioactive plant compounds commonly used in herbal dietary supplements and their relative toxicities. Using primarily the National Library of Medicine journal database and SciFinder for current reports, 47 toxic compounds in 55 species from 46 plant families were found to demonstrate harmful effects due to hepatic, cardiovascular, central nervous system, and digestive system toxicity. This review further contributes a novel and comprehensive view of toxicity across the botanical dietary market, and investigates the toxicity of the top ten botanical dietary supplements purchased in the United States of America to gauge the exposure risk of toxicity to the public. The criteria of measuring toxicity in this review (plant compound, family, quantity, and toxicity effects) across the entire market in the United States, with special attention to those supplements whose exposure to the consumer is maximal, provides a unique contribution to the investigation of botanical supplements.

Key words

toxicity - botanical - dietary supplements - plant - compound

* These two authors contributed equally to this work.


 

  • References

  • 1 Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers Pharm 2013; 4: 177
    PubMedGoogle Scholar
  • 2 Camire ME, Kantor MA. Dietary supplements: nutritional and legal considerations. Food Tech 1999; 7: 87-96
    PubMedGoogle Scholar
  • 3 Barnes PM, Bloom B, Nahin R. CDC National Health Statistics Report #12. Complementary and Alternative Medicine Use Among Adult Child. Available at: https://www.ncbi.nlm.nih.gov/pubmed/19361005 Accessed October 8, 2016
    PubMedGoogle Scholar
  • 4 Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Nat Health Stat Report 2009; 18: 1-14
    PubMedGoogle Scholar
  • 5 Global Industry Analysts, Inc. (GIA). Herbal Supp Rem Mark; 2015. Available at: http://www.strategyr.com/MarketResearch/Herbal_Supplements_and_Remedies_Market_Trends.asp/ Accessed February 2, 2017
    PubMedGoogle Scholar
  • 6 U. S. Food and Drug Administration. Background on the FDA Food Safety Modernization Act (FSMA); 2018. Available at https://www.fda.gov/NewsEvents/PublicHealthFocus/ucm239907.htm Accessed December 28, 2017
    PubMedGoogle Scholar
  • 7 National Center for Complementary and Integrative Health. Ephedra. National Institutes of Health. U.S. Department of Health and Human Services; 2015. Available at https://nccih.nih.gov/health/ephedra Accessed November 30, 2016
    PubMedGoogle Scholar
  • 8 Lewis CJ. Safety alerts and advisories – FDA advises dietary supplement manufacturers to remove comfrey products from the market; 2001. Available at: https://www.fda.gov/Food/RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm111219.htm Accessed April 14, 2017
    PubMedGoogle Scholar
  • 9 Farina EK, Austin KG, Lieberman HR. Concomitant dietary supplement and prescription medication use is prevalent among US adults with doctor-informed medical conditions. J Acad Nutr Diet 2014; 114: 1784-1790.e2
    CrossrefPubMedGoogle Scholar
  • 10 Smith T, Kimberly K, Eckl V, Morton C, Stredney R. Herbal supplement sales in US increase 7.7 % in 2016. HerbalGram: Amer Botan Counc 2017; 115: 11
    PubMedGoogle Scholar
  • 11 Dong X. Emodin: a Review of its Pharmacology, Toxicity and Pharmacokinetics. New York City: John Wiley & Sons, Ltd.; 2016
    Google Scholar
  • 12 Bottenberg MM, Wall GC, Harvey RL, Habib S. Oral aloe vera-induced hepatitis. An Pharmacother 2007; 41: 1740-1743
    PubMedGoogle Scholar
  • 13 Lee J, Lee MS, Nam KW. Acute toxic hepatitis caused by an Aloe vera preparation in a young patient: a case report with a literature review. Korean J Gastro 2014; 64: 54-58
    PubMedGoogle Scholar
  • 14 Yang HN, Kim DJ, Kim YM, Kim BH, Sohn KM, Choi MJ, Choi YH. Aloe-induced toxic hepatitis. J Korean Med Sci 2010; 3: 492-495
    PubMedGoogle Scholar
  • 15 Toxicology Data Network. Anthraquinone. National Institutes of Health; 2006. Available at: https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+2074 Accessed April 23, 2017
    PubMedGoogle Scholar
  • 16 Dai JP, Wang QP, Su Y, Gu LM, Zhao Y, Chen XX, Chen C, Li WZ, Wang GF, Li KS. Emodin inhibition of influenza A virus replication and influenza viral pneumonia via the Nrf2, TLR4, p 38/JNK and NF-kappaB pathways. Molecules 2017; 22: 1754/1-1754/17
    PubMedGoogle Scholar
  • 17 Zhang Z, Chen S, Mei H. Ginkgo biloba leaf extract induces DNA damage by inhibiting topoisomerase II activity in human hepatic cells. Sci Rep 2015; 5: 14633
    CrossrefPubMedGoogle Scholar
  • 18 National Center for Complementary and Integrative Health. Ginkgo. National Institutes of Health; 2017. Available at: https://nccih.nih.gov/health/ginkgo/ataglance.htm Accessed April 23, 2017
    PubMedGoogle Scholar
  • 19 Gardner Z, McGuffin M. American Herbal Products Associationʼs botanical Safety Handbook. 2nd ed.. ed. Boca Raton, FL: CRC Press; 2013: 834-837
    Google Scholar
  • 20 Bach N, Thung SN, Schaffner F. Comfrey herb tea-induced hepatic veno-occlusive disease. Amer J Med 1989; 87: 97-99
    CrossrefPubMedGoogle Scholar
  • 21 Clinical and Research Information on Drug-induced Liver Injury. Comfrey. LiverTox 2014. Available at: https://livertox.nih.gov/Comfrey.htm Accessed April 23, 2017
    PubMedGoogle Scholar
  • 22 Fu PP, Yang YC, Xia Q, Chou MC, Cui YY, Lin G. Pyrrolizidine alkaloids-tumorigenic components in Chinese herbal medicines and dietary supplements. J Food Drug Anal 2002; 10: 198-211
    PubMedGoogle Scholar
  • 23 European Medicines Agency – Committee of Herbal Medicinal Products. Public statement on contamination of herbal medicinal products/traditional herbal products with pyrrolizidine alkaloids. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Public_statement/2016/06/WC500208195.pdf Accessed April 24, 2017
    PubMedGoogle Scholar
  • 24 Gardner Z, McGuffin M. American Herbal Products Associationʼs botanical Safety Handbook. 2nd ed.. ed. Boca Raton, FL: CRC Press; 2013: 900-902
    Google Scholar
  • 25 Gardner Z, McGuffin M. American Herbal Products Associationʼs botanical Safety Handbook. 2nd ed.. ed. Boca Raton, FL: CRC Press; 2013: 498-502
    Google Scholar
  • 26 Arteaga S, Andrade-Cetto A, Cárdenas R. Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid. J Ethnopharm 2005; 98: 231-239
    CrossrefPubMedGoogle Scholar
  • 27 Moro PA, Cassetti F, Giugliano G, Falce MT, Mazzanti G, Menniti-Ippolito F, Raschetti R, Santuccio C. Hepatitis from greater celandine (Chelidonium majus L.): review of literature and report of a new case. J Ethnopharm 2009; 124: 328-332
    CrossrefPubMedGoogle Scholar
  • 28 Teschke R, Glass X, Schulze J. Herbal hepatotoxicity by greater celandine (Chelidonium majus): causality assessment of 22 spontaneous reports. Reg Tox Pharm 2011; 61: 282-291
    CrossrefPubMedGoogle Scholar
  • 29 Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: a tabular compilation of reported cases. Liver Int 2012; 32: 1543-1556
    CrossrefPubMedGoogle Scholar
  • 30 Madyastha KM, Raj CP. Effects of Menthofuran, a Monoterpene Furan on Rat Liver microsomal Enzymes, in vivo . Amsterdam: Elsevier; 1994: 119-125
    Google Scholar
  • 31 Woolf A. Essential Oil Poisoning. United Kingdom: Taylor & Francis Group; 1999: 721-727
    Google Scholar
  • 32 Chalasani N, Vuppalanchi R, Navarro V, Fontana R, Bonkovsky H, Barnhart H, Kleiner DE, Hoofnagle JH. Acute liver injury due to flavocoxid (Limbrel), a medical mood for osteoarthritis: a case series. Ann Intern Med 2012; 156: 857-860
    CrossrefPubMedGoogle Scholar
  • 33 Bedada W, Andres F, Engidawork E, Pohanka A, Beck O, Bertilsson L, Llerena A, Aklilu E. The psychostimulant khat (Catha edulis) inhibits CYP2D6 enzyme activity in humans. J Clin Psychopharm 2015; 35: 694-699
    CrossrefPubMedGoogle Scholar
  • 34 Clinical and Research Information on Drug-induced Liver Injury. Khat. LiverTox 2013. Available at: https://livertox.nlm.nih.gov/Khat.htm Accessed April 23, 2017
    PubMedGoogle Scholar
  • 35 Forbes MP, Raj AS, Martin J, Lampe G, Powell EE. Khat-associated hepatitis. Med J Aust 2013; 199: 498-499
    CrossrefPubMedGoogle Scholar
  • 36 Stuyt R, Willems SM, Wagtmans MJ, van Hoek B. Hepatotoxicity of khat chewing. Liver Int 2001; 31: 434-436
    PubMedGoogle Scholar
  • 37 Kamalu BP. Pathological changes in growing dogs fed on a balanced cassava (Manihot esculenta Crantz) diet. Br J Nutr 1993; 69: 921-934
    CrossrefPubMedGoogle Scholar
  • 38 Kangas-Dick A, Khan U, Awoniyi O, Waqar S, Tun NN, Viswanathan K, Wong C. A case of chronic calcific nonalcoholic pancreatitis. Case Reps Gastrointest Med 2016; 2016: 2963681
    PubMedGoogle Scholar
  • 39 U. S. Food and Drug Administration. International drug scheduling: convention on psychotropic substances 2005. Available at: https://www.fda.gov/ohrms/dockets/98fr/05-23958.htm Accessed February 16, 2018
    PubMedGoogle Scholar
  • 40 Funk JL, Frye JB, Oyarzo JN, Zhang H, Timmermann BN. Anti-arthritic effects and toxicity of the essential oils of turmeric (Curcuma longa L.). J Agric Food Chem 2010; 58: 842-849
    CrossrefPubMedGoogle Scholar
  • 41 Chopra A, Saluja M, Tillu G, Venugopalan A, Narsimulu G, Sarmukaddam S, Patwardhan B. Evaluating higher doses of Shunthi – Guduchi formulations for safety in treatment of osteoarthritis knees: A Government of India NMITLI arthritis project. J Ayurvedic Integ Med 2012; 3: 38-44
    PubMedGoogle Scholar
  • 42 Levorato S, Dominici L, Fatigoni C, Zadra C, Pagiotti R, Moretti M, Villarini M. In vitro toxicity evaluation of estragole-containing preparations derived from Foeniculum vulgare Mill. (fennel) on HepG2 cells. Food Chem Toxicol 2018; 111: 616-622
    CrossrefPubMedGoogle Scholar
  • 43 Probert PM, Palmer JM, Alhusainy W, Amer AO, Rietjens IM, White SA, Jones DE, Wright MC. Progenitor-derived hepatocyte-like (B-13/H) cells metabolise 1′-hydroxyestragole to a genotoxic species via a SULT2B1-dependent mechanism. Toxicol Lett 2016; 243: 98-110
    CrossrefPubMedGoogle Scholar
  • 44 van den Berg SJ, Alhusainy W, Restani P, Rietjens IM. Chemical analysis of estragole in fennel based teas and associated safety assessment using the Margin of Exposure (MOE) approach. Food Chem Toxicol 2014; 65: 147-154
    CrossrefPubMedGoogle Scholar
  • 45 Gardner Z, McGuffin M. American Herbal Products Associationʼs botanical Safety Handbook. 2nd ed.. ed. Boca Raton, FL: CRC Press; 2013: 786-788
    Google Scholar
  • 46 Haller CA, Jacob P, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther 2002; 7: 421-432
    PubMedGoogle Scholar
  • 47 Haller C, Benowitz N. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343: 1833-1838
    CrossrefPubMedGoogle Scholar
  • 48 Gardner Z, McGuffin M. American Herbal Products Associationʼs botanical Safety Handbook. 2nd ed.. ed. Boca Raton, FL: CRC Press; 2013: 5-7
    Google Scholar
  • 49 Ammar EM, Abdelal M, Afifi AM. Role of central cholinergic and adrenergic receptors in mediating the central arrhythmogenic effect of aconitine. Acta Pharm Jug 1976; 26: 223-228
    PubMedGoogle Scholar
  • 50 Parker AJ, Lee JB, Redman J, Jolliffe L. Strychnine poisoning: gone but not forgotten. Emerg Med J 2011; 28: 84-85
    CrossrefPubMedGoogle Scholar
  • 51 Prat S, Hoizey G, Lefrancq T, Saint-Martin P. An unusual case of strychnine poisoning. J Forensic Sci 2015; 60: 816-817
    CrossrefPubMedGoogle Scholar
  • 52 Khan I, Kant C, Sanwaria A, Meena L. Acute cardiac toxicity of nerium oleander/indicum poisoning (kaner) poisoning. Heart Views 2010; 11: 115-116
    CrossrefPubMedGoogle Scholar
  • 53 Osterloh J. Oleander interference in the digoxin radioimmunoassay in a fatal ingestion. JAMA 1982; 247: 1596-1597
    CrossrefPubMedGoogle Scholar
  • 54 Boswell BR, Dorweiler MA, Erbs NC, Caplan JP. A case of Nerium oleander toxicity: a thorny predicament. Psychosomatics 2014; 54: 379-381
    PubMedGoogle Scholar
  • 55 Gupta A, Joshi P, Jortani SA, Valdes jr. R, Thorkelsson T, Verjee Z, Shemie S. A case of nondigitalis cardiac glycoside toxicity. Ther Drug Monit 1997; 19: 711-714
    CrossrefPubMedGoogle Scholar
  • 56 Abbassi MH, Fatima S, Khawar MB, Naz N, Mujeeb KA, Akhtar T, Sheikh N. Dose-dependent acute phase response of aqueous leaf decoction of Nerium oleander in Wistar rats. J Biol Regul Homeost Agents 2017; 31: 985-989
    PubMedGoogle Scholar
  • 57 Gardner Z, McGuffin M. American Herbal Products Associationʼs botanical Safety Handbook. 2nd ed.. ed. Boca Raton, FL: CRC Press; 2013: 633-635
    Google Scholar
  • 58 Hess A, Sullivan D. Potential for toxicity with use of bitter orange extract and guarana for weight loss. Cedarville, Ohio: Pharmacy Practice Faculty Publications; 2005: 2-3
    Google Scholar
  • 59 Canders CP, Stanford SR, Chiem AT. A dangerous cup of tea. Wilderness Environ Med 2014; 25: 111-112
    CrossrefPubMedGoogle Scholar
  • 60 Subbiah MT, Ravi YM. Studies on the nature of anti-platelet aggregatory factors in the seeds of the amazonian herb Guarana (Paullinia cupana). Intl J Vit Nutr Res 2008; 78: 96-101
    PubMedGoogle Scholar
  • 61 Haller CA, Duan M, Benowitz NL, Jacob P. Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements. J Anal Toxicol 2004; 28: 145-151
    CrossrefPubMedGoogle Scholar
  • 62 Dunnick JK, Nyska A. The toxicity and pathology of selected dietary herbal medicines. Toxicol Pathol 2012; 41: 374-386
    PubMedGoogle Scholar
  • 63 Kumar S, Yadav JP. Ethnobotanical and pharmacological properties of Aloe vera: a review. J Med Plants Res 2014; 8: 1387-1398
    PubMedGoogle Scholar
  • 64 Guo X, Nan M. Aloe vera: A review of toxicity and adverse clinical effects. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2016; 34: 77-96
    CrossrefPubMedGoogle Scholar
  • 65 Gardner Z, McGuffin M. American Herbal Products Associationʼs botanical Safety Handbook. 2nd ed.. ed. Boca Raton, FL: CRC Press; 2013: 799-801
    Google Scholar
  • 66 Gosselin RE, Smith RP, Hodge HC. Clinical Toxicology of commercial Products, 5th ed. Baltimore, MD: Williams & Wilkins; 1984
    Google Scholar
  • 67 Delbart F, Brams M, Gruss F, Noppen S, Boland S, Chaltin P, Brandao-Neto S, von Delft F, Touw WG, Joosten RP, Liekens S, Tytgat J, Ulens C. An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein. J Biochem 2018; 293: 2534-2545
    PubMedGoogle Scholar
  • 68 Jacobs KL. United States Pharmacopeia (USP) Admission Evaluation of European Elderberry dry Extract. Rockville, Maryland: Dietary Supplements Admission Evaluations Joint Standards-Setting Subcommittee; 2017: 46-47
    Google Scholar
  • 69 Corazza O, Martinotti G, Santacroce R, Chillemi E, Giannantonio MD, Schifano F, Cellek S. Sexual enhancement products for sale online: raising awareness of the psychoactive effects of yohimbine, maca, horny goat weed, and Ginkgo biloba . Biomed Res Int 2014; 2014: 841798
    PubMedGoogle Scholar
  • 70 Myeong SL. Maca (Lepidium meyenii) for treatment of menopausal symptoms: a systematic review. Maturitus 2011; 70: 227-233
    CrossrefPubMedGoogle Scholar
  • 71 Gardner Z, McGuffin M. American Herbal Products Associationʼs botanical Safety Handbook. 2nd ed.. ed. Boca Raton, FL: CRC Press; 2013: 771-773
    Google Scholar
  • 72 Gardner Z, McGuffin M. American Herbal Products Associationʼs botanical Safety Handbook. 2nd ed.. ed. Boca Raton, FL: CRC Press; 2013: 179-182
    Google Scholar
  • 73 Datta S, Mahdi F, Ali Z, Khan IA, Jekabsons MB, Nagle DG, Zhou YD. Toxins from botanical dietary supplements: blue cohosh components disrupt mitochondrial membrane integrity and impair cellular respiration. Planta Medica 2013; 79: PH23
    Article in Thieme ConnectPubMedGoogle Scholar
  • 74 Rader JI, Pawar RS. Primary constituents of blue cohosh: quantification in dietary supplements and potential for toxicity. Anal Bioanal Chem 2013; 13: 4409-4417
    PubMedGoogle Scholar
  • 75 U. S. Food and Drug Administration. Caffeine and kids: FDA takes a closer look. 2013. Available at: https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm350570.htm Accessed March 13, 2018
    PubMedGoogle Scholar
  • 76 Netto AB, Netto CM, Mahadeyan A, Taly AB, Agadi JB. Tropical ataxic neuropathy – a century old enigma. Neurol India 2016; 6: 1151-1159
    PubMedGoogle Scholar
  • 77 Rivadeneyra-Domínguez E, Vázquez-Luna A, Rodríguez-Landa JF, Díaz-Sobac R. Neurotoxic effect of linamarin in rats associated with cassava (Manihot esculenta Crantz) consumption. Food Chem Toxicol 2013; 59: 230-235
    CrossrefPubMedGoogle Scholar
  • 78 Ballantyne B, Snellings WM. Triethylene glycol HO(CH2CH2O)3H. J Appl Toxicol 2007; 27: 291-299
    CrossrefPubMedGoogle Scholar
  • 79 Wang J, van der Heijden R, Spruit S, Hankermeier T, Chan K, van der Greef J, Xu G, Wang M. Quality and safety of Chinese herbal medicines guided by a systems biology perspective. J Ethnopharm 2009; 126: 31-41
    CrossrefPubMedGoogle Scholar
  • 80 Raut AA, Rege NN, Tadvi FM, Solanki PV, Kene KR, Shirolkar SG, Vaidya AB. Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteers. J Ayurveda Integ Med 2012; 3: 111-114
    PubMedGoogle Scholar
  • 81 Jadot ICA, Declèves AE, Nortier J, Caron N. An integrated view of aristolochic acid nephropathy: update of the literature. Int J Mol Sci 2017; 18: 297
    CrossrefPubMedGoogle Scholar
  • 82 Schmeiser H, Bieler C, Wiessler M, van Ypersele de Strihou C, Cosyns JP. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 1996; 56: 2025-2028
    PubMedGoogle Scholar
  • 83 Debelle F, Vanherweghem J, Nortier J. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008; 74: 158-169
    CrossrefPubMedGoogle Scholar
  • 84 Gardner Z, McGuffin M. American Herbal Products Associationʼs botanical Safety Handbook. 2nd ed.. ed. Boca Raton, FL: CRC Press; 2013: 561-564
    Google Scholar
  • 85 Hoang ML, Chen CH, Chen PC, Roberts NJ, Dickman KG, Yun BH, Turesky RJ, Pu YS, Vogelstein B, Papadopoulas N, Grollman AP, Kinzler KW, Rosenquist TA. Aristolochic acid in the etiology of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 2016; 25: 1600-1608
    CrossrefPubMedGoogle Scholar